Renal and urologic disorders

Applied filters

Renal and urologic disorders

COVID-19 Medicines Optimisation (1)
- COVID-19 Medicines Optimisation: Specialty Guidance (1)
Care Setting (5)
- Paediatrics and neonates (3)
- Primary Care (2)
Guidance (33)
- Best Practice Sharing (1)
- Complementary medicines (1)
- Dosing (4)
- Excipients (1)
- Safety in Breastfeeding (19)
- Stability in dosette boxes (21)
- Stability outside the fridge (1)
- Supply (1)
Interest areas (1)
- Medicines Safety (1)
Medicine (60)
- Alfuzosin (2)
- Arginine + Lysine (1)
- Atorvastatin (1)
- Avanafil (1)
- Bethanechol (2)
- Botulinum A toxin (1)
- Clonidine (1)
- Colestilan (1)
- Dalteparin (2)
- Dapoxetine (1)
- Darifenacin (2)
- Desmopressin (1)
- Doxazosin (1)
- Duloxetine (2)
- Dutasteride (2)
- Enoxaparin (2)
- Etidronate disodium (1)
- Fesoterodine (1)
- Finasteride (1)
- Flavoxate (1)
- Fluvastatin (1)
- Gabapentin (1)
- Ibandronic acid (1)
- Imipramine (1)
- Lactose (1)
- Lanthanum carbonate (1)
- Lidocaine + Prilocaine (1)
- Lovastatin (1)
- Medroxyprogesterone (1)
- Megestrol (1)
- Methotrexate (1)
- Mirabegron (2)
- Mitomycin (1)
- Oxybutynin (2)
- Pamidronate disodium (1)
- Pamidronic acid (1)
- Pentosan polysulfate sodium (1)
- Potassium citrate (1)
- Pravastatin (1)
- Prazosin (1)
- Propantheline (1)
- Propiverine (2)
- Risedronate sodium (1)
- Risedronic acid (1)
- Rosuvastatin (1)
- Sevelamer (1)
- Sildenafil (1)
- Simvastatin (1)
- Simvastatin + Ezetimibe (1)
- Sodium bicarbonate (2)
- Sodium chloride (1)
- Sodium citrate (1)
- Sodium clodronate (1)
- Sodium thiosulfate (1)
- Sodium thiosulphate (1)
- Solifenacin (2)
- Solifenacin + Tamsulosin (2)
- Tadalafil (1)
- Tamsulosin (2)
- Tamsulosin + Dutasteride (1)
- Testosterone (1)
- Tinzaparin (2)
- Tolterodine (2)
- Trospium (2)
- Vardenafil (1)
- Zoledronic acid (1)
Planning (51)
- Advanced therapy medicinal products (4)
- New Medicines (36)
  - CCG commissioned new medicines (21)
  - NHS England commissioned new medicines (19)
  - Pre-registration new medicines (UK/EU) (4)
- Patent expiries (20)
Publications (7)
- Bulletins and summaries (7)
Specialty (84)
- Allergy and immunology (3)
- Anaesthesia and pain (1)
- Cancers (4)
- Cardiovascular system disorders (6)
- Ear, nose and throat disorders (2)
- Endocrine system disorders (2)
- Eyes and vision (1)
- Gastrointestinal disorders (5)
- Haematological disorders (8)
- Infection and infectious diseases (1)
- Liver disorders (1)
- Mental health and illness (1)
- Musculo-skeletal disorders (2)
- Neurological disorders (2)
- Nutritional and metabolic disorders (6)
- Obstetrics and gynaecology (13)
- Renal and urologic disorders (84)
- Respiratory disorders (1)
- Sexual health (1)
- Surgery (1)

Iptacopan

20 January 2021dm+d: Unassigned

New Medicines

Summary of COVID-19 medicines guidance: Renal and urologic disorders

24 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and renal and urologic disorders.…

Summary of NICE guidance for Anaemia management in people with CKD

13 November 2020This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any updates to this guideline.…

Summary of NICE guidance for Hyperphosphataemia in CKD / Urinary incontinence

8 November 2020Since this edition of NICE Bites was published, NICE has indicated it is updating its recommendations on the cost-effectiveness of phosphate binders in this CKD…

Summary of NICE guidance for Chronic kidney disease

8 November 2020Since this edition of NICE Bites was published, NICE has indicated it is updating the recommendations on investigations for and classification of chronic kidney disease…

Summary of NICE guidance for LUTS in men / Constipation in children and young people

3 November 2020Since this edition of NICE Bites was published, NICE has updated these guidelines. CG97 includes a recommendation not to offer phosphodiesterase-5-inhibitors for the purpose of…

Summary of NICE guidance for Nocturnal enuresis

2 November 2020This edition of NICE Bites reflects current NICE guidance (as at November 2020) .Please go to NICE for any recent updates to this guideline. NICE…

Can oral bisphosphonates be given to people with renal impairment to treat osteoporosis?

9 July 2020In the main, bisphosphonates are not metabolised and are excreted unchanged in urine. Oral bisphosphonates are licensed for the primary and secondary prevention of osteoporotic…

Does horny goat weed have any clinically significant interactions?

3 May 2020Horny goat weed (Epimedium) is a herbal medicine that may comprise of mixtures of different related Epimedium species, which contain numerous and varied active constituents. …

How can hot flushes in men being treated for prostate cancer be managed?

28 April 2020This updated Medicines Q&A evaluates the available evidence for the different treatment options for hot flushes in men treated for prostate cancer

SPS - Specialist Pharmacy Service

NHS